Nymox Pharmaceutical Corp Stock price
Is Nymox Pharmaceutical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Don't miss a Thing! We will send you all news about Nymox Pharmaceutical Corp directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Nymox Pharmaceutical Corp Stock News
Company Profile
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
| Head office | Bahamas |
| CEO | Dr. Averback |
| Employees | 18 |
| Founded | 1995 |
| Website | nymox.com |


